India, Jan. 1 -- The Pharmaceuticals Export Promotion Council of India (Pharmexcil) convened its 21st Annual General Meeting (AGM) on December 29, 2025, marking a defining moment in India's pharmaceutical export journey. The AGM underscored the sector's strategic pivot from volume-led growth to value-driven, innovation-oriented, and sustainability-anchored manufacturing.

Deliberations at the AGM highlighted the industry's transition towards complex generics, speciality APIs, and advanced therapeutic platforms. Technical sessions and panel discussions reinforced the growing relevance of green and sustainable chemistry, with particular emphasis on flow chemistry and continuous manufacturing as enablers of consistent quality, regulatory com...